Like many of you, weare also very excited by the Chan Zuckerberg Initiative announcement. Here’s what we know so far: Rather than funding direct cures, the initiative will fund basic science research, asking questions like how cells divide or how proteins fold. The expectation is that answers to...
The following article describes the first clinical use of of intrathecal MSC-NPs in 6 patients with progressive MS. An average followup of 7 years demonstrated both short and long term safety of the treatment. Four of the six patients showed a measurable clinical improvement following MSC-NP...
Stars Come Out to Help End Multiple Sclerosis at Tisch MS Research Center of New York’s Future Without MS Gala New York, NY- November 1, 2016- The Tisch MS Research Center of New York (Tisch MSRCNY) announced today that their continued efforts to raise $10 million for the Center’s unprecedented...
Did you know you’re leaving valuable donations toward a Future Without MS on the table every time you shop on Amazon without connecting to Amazon Smile? What is AmazonSmile? AmazonSmile is a simple and automatic way for you to support the Tisch MS Research Center at no cost to you. When you log on...
Tisch MSRCNY is preparing for construction to commence January 2017 of a state-of-the-art stem cell facility on our 3rd floor. This could not have been done without the generosity of our supporters. The build-out of our new research laboratory enables Phase II of the Tisch MSRCNY FDA-approved stem...
Congratulations to Dr. Saud A. Sadiq who has been recognized in Castle Connolly's " America's Top Doctors " 14th ed. and "Top Doctors: New York Metro Area" 18th ed. The mission of Castle Connolly Medical Ltd. is to help consumers find the best healthcare. To this end, they publish a variety of...
We are currently the only center in the United States that is conducting an FDA approved clinical trial using stem cells in patients with MS. The goal of the Phase I trial is to determine whether or not the therapy is safe and effective. We hope that this will lead to additional future trials and...